Diabetes patients taking GLP-1 inhibitors were 41% less likely to develop heart failure compared with those on other glucose-lowering medications, a study indicated. Researchers also found the patients on GLP-1 inhibitors had a 44% lower risk of all-cause hospitalization and an 80% lower risk of all-cause mortality than those not on such medications. The findings were presented at the American College of Cardiology meeting.

Related Summaries